12 Recruiting Systemic Lupus Erythematosus Phase 2 Clinical Trials
Active phase 2 studies for systemic lupus erythematosus enrolling across the USA. Verify eligibility and contact site coordinators.
All Systemic Lupus Erythematosus studiesPhase 2 Studies for Systemic Lupus Erythematosus
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
📍 Onyx Clinical Research — Peoria, Arizona
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
📍 Local Institution - 0100 — Birmingham, Alabama
View Study & Checklist ➔Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
📍 Accel Research Sites Network - Birmingham- Site Number : 8400003 — Vestavia Hills, Alabama
View Study & Checklist ➔Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Centrally Acting ACE Inhibition in SLE
📍 Yale University School of Medicine — New Haven, Connecticut
View Study & Checklist ➔The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
📍 The Lundquist Institute at Harbor-UCLA Medical Center — Torrance, California
View Study & Checklist ➔Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
📍 GSK Investigational Site — Cincinnati, Ohio
View Study & Checklist ➔Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
📍 HonorHealth Research and Innovation Institute — Scottsdale, Arizona
View Study & Checklist ➔RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
📍 University of California Irvine — Orange, California
View Study & Checklist ➔The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
📍 Wallace & Lee Center — Beverly Hills, California
View Study & Checklist ➔